(redirected from Blast count)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for leukemia

References in periodicals archive ?
Identification of the cytogenetic fusion transcripts is considered diagnostic of acute leukemia, even when the blast count is less than 20%.
An increased blast count is suggested by an increased percentage of CD34-positive cells.
If there are more than 50% erythroid precursors, the erythroid progenitors are also excluded from the blast count.
The notable peripheral blood monocytosis (2,000/ml) and bone marrow blast count of 10% were indicative of CMML, and flow cytometry immunophenotypic analysis and special staining were confirmatory.
If the blast count is less than 20% of all nucleated cells and also less than 20% of the nonerythroid elements, a diagnosis of MDS is most appropriate.
Results of Bone Marrow Studies Initial Admission 3 Weeks Later With Varicella With ALL Cellularity Decreased 100% increased Morphology Decreased in all cell lines Total replacement by ALL-L, blasts Blast count 0% 82% Megakaryocytes Decreased Absent ALL = Acute lumphocytic leukemia.
The assay helped resolve complex cytogenetic cases, positively identified the expected fusion transcript in RNA samples from cases with low blast count, and resulted in 99% agreement (196/198)* with standard cytogenetic methods.
In phase I and II clinical trials in patients who have a limited number of approved treatments for their diseases, rigosertib has demonstrated significant bone marrow blast count improvement (at least 50% blast reduction) in 53% of MDS patients and greater than 50% reduction in CA 19-9 marker in about 36% of patients with pancreatic cancer.
Na resulted in significant decrease in blast count (cancer cells) in bone marrow without significant toxicity in these high risk MDS patients.
Among four MDS patients with aggressive disease that had progressed following azacitidine or decitabine treatment, one achieved complete remission and two achieved a decrease in bone marrow blast count to 5% or less.